Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nestorone-Testosterone Gel in Healthy Men
NCT02432261Phase 1Completed
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of segesterone in male contraception (2 arms). Primary endpoint: Gonadotropin Suppression at 4 weeks. Started Apr 2015; status: completed.
02
Drugs
segesterone
03
Conditions
male contraception
Beyond the preview
Go deeper on NCT02432261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432261.